Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | CGEN Compugen Ltd. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $2.49 +1.2% | $15.06 -2.0% |
| StockIQ Score | 51C- Moderate Risk: High | 36F Weak Risk: Medium |
| Technical | 48D+ | 13F |
| Fundamental | — | 35F |
| Growth | — | 50C- |
| Fair Value | — | 38F |
| News | 62C+ | 50C- |
| Quality | — | 50C- |
| Risk | 42D | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
CGEN leads with an investor score of 51 and a technical score of 49, both well above AAPG’s 35 and 13 respectively. AAPG, however, has available fundamental, growth and valuation scores—35, 50 and 38—while CGEN lacks those metrics. Thus CGEN appears stronger in investor and technical categories, whereas AAPG shows a higher growth score among the scores it reports.